CAS 1629138-41-5

SRI-011381

CAS : 1629138-41-5

SRI-011381

Degré de pureté : ≥98%

Masse moléculaire : 329.48g/mol

Ref: 54-BUP12892

SRI-011381

CAS : 1629138-41-5

Formule : C₂₀H₃₁N₃O

Masse moléculaire : 329.49

Ref: 4Z-K-031087

SRI-011381

CAS : 1629138-41-5

SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.

Formule : C₂₀H₃₁N₃O

Degré de pureté : 98.64%

Couleur et forme : Solid

Masse moléculaire : 329.48

Ref: TM-T4283

SRI-011381

CAS : 1629138-41-5

SRI-011381 is a novel small molecule inhibitor of the ubiquitin proteasome pathway. It inhibits the degradation of proteins by inhibiting the activity of the ubiquitin proteasome, which is required for protein synthesis. SRI-011381 has been shown to inhibit tumor growth in vivo and in vitro, as well as prevent the development of cancer tissues. This drug also has anti-inflammatory properties and may be useful for treating idiopathic urticaria. SRI-011381 has strong antimicrobial activity against Gram-positive bacteria, such as methicillin resistant Staphylococcus aureus (MRSA) and Bacillus cereus. It also inhibits growth factor β1, which is responsible for proliferation in cells with metabolic disorders.

Formule : C₂₀H₃₁N₃O

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 329.48 g/mol

Ref: 3D-EQC13841

1-Benzyl-3-cyclohexyl-1-(piperidin-4-ylmethyl)urea

CAS : 1629138-41-5

Formule : C₂₀H₃₁N₃O

Degré de pureté : ≥98%

Masse moléculaire : 329.488

Ref: 10-F544731